Piperlongumine overcomes imatinib resistance by inducing proteasome inhibition in chronic myelogenous leukemia cells.
J Ethnopharmacol
; 301: 115815, 2023 Jan 30.
Article
in En
| MEDLINE
| ID: mdl-36220508
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Biological Products
/
Leukemia, Myelogenous, Chronic, BCR-ABL Positive
/
Antineoplastic Agents
Limits:
Animals
/
Humans
Language:
En
Journal:
J Ethnopharmacol
Year:
2023
Document type:
Article
Country of publication: